查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433533

細胞治療市場規模、佔有率、趨勢分析報告：按治療類型、治療領域、地區、細分市場預測，2024-2030

Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

細胞治療市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球細胞治療市場規模將達到200.7億美元，2024年至2030年複合年成長率為22.66%。

市場相關人員對開拓先進的組織、基因和細胞治療方法越來越感興趣。研究界和公司繼續大量投資培養和分離多種細胞類型，包括角質形成細胞、軟骨細胞、軟骨細胞、幹細胞、真皮乳頭細胞和上皮細胞，以開發新的治療方法。

FDA 等監管機構透過舉措開發和核准先進治療方法並限制不受監管的治療方法，在市場成長中發揮關鍵作用。此外，直接細胞重編程由於其有效性和安全性等優勢，作為一種尖端治療方法而受到關注。

同時，與先進治療相關的臨床試驗數量的增加預計將在未來幾年推動市場成長。根據美國基因與細胞治療學會獲得的資料，2022年第一季啟動了32項非重組細胞療法臨床試驗，其中69%是非重組腫瘤領域。此外，根據 ClinicalTrials.gov 的數據，超過 1,800 種細胞療法正在進行臨床試驗。

此外，市場上營運的主要企業正在採取多項策略舉措，例如各種協議、新產品推出和業務擴展，以增強其在市場上的影響力。例如，2022年5月，賓州大學的個人化細胞療法已被核准用於治療復發或難治性濾泡性淋巴瘤。

此外，2021年4月，百時美施貴寶宣布美國FDA核准了Brayange (lysocabtagene malaleucel)，這是一種新型 CAR T 療法，用於治療成人 R/R 大 B 細胞淋巴瘤患者。在 3L+LBCL 的關鍵臨床試驗 TRANSCEND NHL 001 中，Breyanzi 表現出 73% 的整體緩解率和 54% 的完全緩解 (CR)。

細胞治療市場報告亮點

  • 由於危及生命的併發症的風險較低且該治療方法的採用率不斷增加，自體細胞療法細分市場在 2023 年佔據了市場的最大銷售佔有率，達到 91.22%。
  • 由於高定價和幹細胞庫的成長等因素，同種異體治療領域預計將在未來幾年顯著成長。此外，許多公司正準備將業務轉向同種異體細胞治療產品開發。
  • 由於擴大採用先進的細胞療法來治療各種類型的癌症，癌症治療領域在 2023 年獲得了最大的市場佔有率。
  • 細胞療法也被考慮用於肌肉骨骼疾病，並且具有巨大的市場成長潛力。
  • 北美由於其強大的法律規範、國際細胞治療協會等機構的存在以及主要營運公司的存在而主導了市場。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 附隨市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章細胞治療市場分類：治療類型估計與趨勢分析

  • 同種異體細胞療法
    • 同種異體細胞療法的全球市場，2018-2030
    • 幹細胞療法
    • 非幹細胞療法
  • 自體細胞療法
    • 2018-2030年全球自體細胞治療市場
    • 幹細胞療法
    • 非幹細胞療法

第5章細胞治療市場分類：治療面積估計與趨勢分析

  • 細胞治療市場：治療領域波動分析
  • 腫瘤學
    • 腫瘤細胞治療的全球市場，2018-2030
  • 心血管疾病（CVD）
    • 心血管疾病細胞療法的全球市場
  • 肌肉骨骼疾病
    • 治療肌肉骨骼疾病的細胞療法的全球市場，2018-2030
  • 皮膚科
    • 皮膚科治療細胞療法的全球市場，2018-2030
  • 其他
    • 其他治療方法的全球細胞治療市場，2018-2030

第6章 細胞治療市場分類：區域估計與趨勢分析

  • 北美洲
  • 歐洲
  • 亞太地區
  • 世界其他地區

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/名單
    • Novartis AG
    • Gilead Sciences, Inc.
    • Bristol-Myers Squibb Company
    • Johnson &Johnson Services, Inc
    • JCR Pharmaceuticals Co., Ltd.
    • JW Therapeutics
    • Atara Biotherapeutics
    • MEDIPOST
    • Anterogen Co., Ltd.
    • S. BIOMEDICS
Product Code: GVR-2-68038-701-8

Cell Therapy Market Growth & Trends:

The global cell therapy market size is expected to reach USD 20.07 billion by 2030, expanding at a CAGR of 22.66% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market players are witnessing an increasing interest in the development of advanced therapies that are based on tissue, genes, or cells. Research communities and companies continue to make large investments in the culturing and isolation of a broad range of cell types, such as keratinocytes, chondrocytes, cartilage, stem, dermal papilla, & epithelial cells for the development of novel therapies.

Regulatory authorities such as FDA play a crucial role in the growth of the market by undertaking initiatives related to the development and approval of advanced treatment development as well as restriction of unregulated treatments. In addition, direct cellular reprogramming is attracting interest as a cutting-edge treatment approach because of its advantages such as efficacy and security.

On the other hand, an increase in the number of clinical trials related to advanced therapies is expected to boost the market growth in the coming years. According to data obtained from the American Society of Gene & Cell Therapy, in Q1 2022, 32 non-genetically modified cellular therapeutics trials were initiated, and 69% of these were in the non-oncology arena. Moreover, according to ClinicalTrials.gov, more than 1800 active cellular therapies are under clinical trial.

Furthermore, key companies operating in the market are undertaking several strategic initiatives such as various agreements, new launches, and expansion to strengthen their market presence. For instance, in May 2022, the University of Pennsylvania's personalized cellular therapy was approved for the treatment of individuals with relapsed or resistant follicular lymphoma.

Moreover, in April 2021, Bristol Myers Squibb declared that U.S. FDA approved its Breyanzi (lisocabtagene maraleucel), a novel CAR T treatment for adults with R/R large B-cell lymphoma. In the pivotal trial for 3L+ LBCL, TRANSCEND NHL 001, Breyanzi showed a 73% overall response rate and a 54% complete response (CR) rate.

Cell Therapy Market Report Highlights:

  • The autologous therapy segment dominated the market with the largest revenue share of 91.22% in 2023, owing to increasing adoption of this therapy type coupled with lower risk of life-threatening complications
  • The allogenic therapy segment is expected to grow significantly in the coming years owing to factors such as high pricing and growth in stem cell banking. Moreover, many companies are preparing to shift their business toward allogenic cell therapy product development
  • Oncology therapeutic area captured the largest market share in 2023, owing to the increasing adoption of advanced cell therapies in the treatment of various types of cancers
  • Cell therapy are also under the investigation for musculoskeletal disorders and has great potential for market growth
  • North America dominated the market owing to the strong regulatory framework, presence of bodies like the International Society for Cellular Therapy, and presence of key operating companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Type Segment
    • 1.1.2. Therapeutic Area Segment
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List Of Secondary Sources
  • 1.8. List Of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Landscape Insights

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rise In The Number Of Clinical Studies Pertaining To The Development Of Cellular Therapies
      • 3.2.1.2 Rising Adoption Of Regenerative Medicine
      • 3.2.1.3 Introduction Of Novel Platforms And Technologies
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Ethical Concerns Related To Stem Cell Research
      • 3.2.2.2 Clinical Issues Pertaining To Development & Implementation Of Cell Therapy
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTEL Analysis
    • 3.3.3 COVID-19 Impact Analysis

Chapter 4 Cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis

  • 4.1 Allogeneic Cell Therapy
    • 4.1.1 Global Allogeneic Cell Therapy Market, 2018 - 2030 (USD Billion)
    • 4.1.2 Stem Cell Therapies
      • 4.1.2.1 Global Allogeneic Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.2.2 Hematopoeitic Stem Cell Therapies
      • 4.1.2.2.1 Global Allogeneic Cell Therapy Market For Hematopoeitic Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.2.3 Mesenchymal Stem Cell Therapies
      • 4.1.2.3.1 Global Allogeneic Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Billion)
    • 4.1.3 Non-Stem Cell Therapies
      • 4.1.3.1 Global Allogeneic Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.3.2 Keratinocytes & Fibroblast-Based Therapies
      • 4.1.3.2.1 Global Allogeneic Cell Therapy Market For Keratinocytes & Fibroblast-Based Therapies, 2018 - 2030 (USD Billion)
      • 4.1.3.3 Others
      • 4.1.3.3.1 Global Allogeneic Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
  • 4.2 Autologous Cell Therapy
    • 4.2.1 Global Autologous Cell Therapy Market, 2018 - 2030 (USD Billion)
    • 4.2.2 Stem Cell Therapy
      • 4.2.2.1 Global Autologous Cell Therapy Market For Stem Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.2.2 BM, Blood, & Umbilical Cord-Derived Stem Cells
      • 4.1.2.2.1 Global Autologous Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cells, 2018 - 2030 (USD Billion)
      • 4.2.2.3 Adipose Derived Cells
      • 4.1.2.3.1 Global Autologous Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Billion)
      • 4.2.2.4 Others
      • 4.2.2.4.1 Global Autologous Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Billion)
    • 4.2.3 Non-Stem Cell Therapy
      • 4.2.3.1 Global Autologous Cell Therapy Market For Non-Stem Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.3.2 T-Cell Therapies
      • 4.2.3.2.1 Global Autologous Cell Therapies Market For T-Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.4.2.2 CAR-T Cell Therapy
      • 4.2.4.2.2.1 Global Autologous Cell Therapy Market For CAR-T Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.4.2.3 T-Cell Receptor (TCR)
      • 4.2.4.2.3.1 Global Autologous Cell Therapy Market For T-Cell Receptor (TCR), 2018 - 2030 (USD Billion)
      • 4.2.3.3 Others
      • 4.2.3.3.1 Global Autologous Cell Therapies Market For Other Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)

Chapter 5 Cell Therapy Market Categorization: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Cell Therapy Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Global Cell Therapy Market For Oncology Therapies, 2018 - 2030 (USD Million)
  • 5.3 Cardiovascular Disease (CVD)
    • 5.3.1 Global Cell Therapy Market For Cardiovascular Disease (CVD) Therapies, 2018 - 2030 (USD Million)
  • 5.4 Musculoskeletal Disorders
    • 5.4.1 Global Cell Therapy Market For Musculoskeletal Disorders Therapies, 2018 - 2030 (USD Million)
  • 5.5 Dermatology
    • 5.5.1 Global Cell Therapy Market For Dermatology Therapies, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Global Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Million)

Chapter 6 Cell Therapy Market Categorization: Regional Estimates & Trend Analysis

  • 6.1 North America
    • 6.1.1 North America Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.2 U.S.
      • 6.1.2.1 Key Country Dynamics
      • 6.1.2.2 Target Disease Prevalence
      • 6.1.2.3 Competitive Scenario
      • 6.1.2.4 Regulatory Framework
      • 6.1.2.6 U.S. Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.3 Canada
      • 6.1.3.1 Key Country Dynamics
      • 6.1.3.2 Target Disease Prevalence
      • 6.1.3.3 Competitive Scenario
      • 6.1.3.4 Regulatory Framework
      • 6.1.3.6 Canada Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2 Europe
    • 6.2.1 Europe Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Germany
      • 6.2.2.1 Key Country Dynamics
      • 6.2.2.2 Target Disease Prevalence
      • 6.2.2.3 Competitive Scenario
      • 6.2.2.4 Regulatory Framework
      • 6.2.2.6 Germany Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 UK
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Target Disease Prevalence
      • 6.2.3.3 Competitive Scenario
      • 6.2.3.4 Regulatory Framework
      • 6.2.3.6 UK Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Switzerland
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 Target Disease Prevalence
      • 6.2.4.3 Competitive Scenario
      • 6.2.4.4 Regulatory Framework
      • 6.2.4.6 Switzerland Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Asia Pacific
    • 6.3.1 Asia Pacific Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 Japan
      • 6.3.2.1 Target Disease Prevalence
      • 6.3.2.2 Competitive Scenario
      • 6.3.2.3 Regulatory Framework
      • 6.3.2.5 Japan Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 China
      • 6.3.3.1 Target Disease Prevalence
      • 6.3.3.2 Competitive Scenario
      • 6.3.3.3 Regulatory Framework
      • 6.3.3.5 China Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 India
      • 6.3.4.1 Target Disease Prevalence
      • 6.3.4.2 Competitive Scenario
      • 6.3.4.3 Regulatory Framework
      • 6.3.4.5 India Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5 South Korea
      • 6.3.5.1 Target Disease Prevalence
      • 6.3.5.2 Competitive Scenario
      • 6.3.5.3 Regulatory Framework
      • 6.3.5.5 South Korea Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Rest Of The World
    • 6.4.1 Rest Of The World Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Categorization
  • 7.2 Strategy Mapping
  • 7.3 Company Market Position Analysis, 2023
  • 7.4 Company Profiles/Listing
    • 7.4.1 Novartis AG
      • 7.4.1.1 Company Overview
      • 7.4.1.4 Financial Performance
      • 7.4.1.3 Product Benchmarking
      • 7.4.1.4 Strategic Initiatives
    • 7.4.2 Gilead Sciences, Inc.
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial Performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic Initiatives
    • 7.4.3 Bristol-Myers Squibb Company
      • 7.4.3.1 Company Overview
      • 7.4.3.2 Financial Performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Johnson & Johnson Services, Inc
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 JCR Pharmaceuticals Co., Ltd.
      • 7.4.5.1 Company Overview
      • 7.4.5.2 Financial Performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 JW Therapeutics
      • 7.4.6.1 Company Overview
      • 7.4.6.2 Financial Performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 Atara Biotherapeutics
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 MEDIPOST
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 Anterogen Co., Ltd.
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 S. BIOMEDICS
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 Global Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 3 Global Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Therapy Market By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 8 U.S. Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 Canada Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 12 Europe Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 14 Europe Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 15 Germany Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 17 UK Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 18 UK Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 Switzerland Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 20 Switzerland Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 China Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 25 China Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 26 Japan Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 27 Japan Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 28 India Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 29 India Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 30 South Korea Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 31 South Korea Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 32 Rest Of The World Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 33 Rest Of The World Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Cell Therapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 PESTEL Analysis
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Global Cell Therapy Market: Therapy Type Key Takeaways
  • Fig. 12 Global Cell Therapy Market: Therapy Type Movement Analysis
  • Fig. 13 Global Cell Therapy Market For Allogeneic Therapies, 2018 - 2030 (USD Million)
  • Fig. 14 Global Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 15 Global Cell Therapy Market For Hematopoetic Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Therapy Market For Keratinocyte & Fibroblast-Based Therapies, 2018 - 2030 (USD Million)
  • Fig. 19 Global Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Therapy Market For Autologous Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell Therapy Market For Autologous Stem-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell Therapy Market For Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Therapy Market For T-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell Therapy Market For CAR T Cell Therapy, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Therapy Market For T Cell Receptor (TCR)-Based, 2018 - 2030 (USD Million)
  • Fig. 29 Global Cell Therapy Market For Other Autologous Non Stem-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 30 Global Cell Therapy Market: Therapeutic Area Key Takeaways
  • Fig. 31 Global Cell Therapy Market: Therapeutic Area Movement Analysis
  • Fig. 32 Global Cell Therapy Market For Oncology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Cell Therapy Market For Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
  • Fig. 34 Global Cell Therapy Market For Musculoskeletal Disorders, 2018 - 2030 (USD Million)
  • Fig. 35 Global Cell Therapy Market For Dermatology, 2018 - 2030 (USD Million)
  • Fig. 36 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Outlook, 2023 & 2030
  • Fig. 38 North America Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 43 UK Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 44 Switzerland Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 50 Rest Of The World Cell Therapy Market, 2018 - 2030 (USD Million)